AVNS - Avanos Medical, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $0.23
|
Rev Est: $169.0M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$26.00
LOW:
$20.00
MEDIAN:
$23.00
CONSENSUS:
$23.00
UPSIDE:
68.62%
Market Cap:
633.15M
Volume:
879,040
Avg Volume:
551,811
52 Week Range:
9.303-16.63
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.09
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
2,227
IPO Date:
2014-10-21
EPS (TTM):
-1.58
P/E Ratio:
N/A
Revenue (TTM):
701.20M
Total Assets:
1.07B
Total Debt:
129.10M
Cash & Equiv:
89.80M
Rev Growth (5Y):
-0.4%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-13.5%
ROCE:
-6.8%
Debt/Equity:
0.17
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.22 | $0.12 | +83.3% | $177.8M | $164.5M | +8.1% |
| 2025-08-05 | $0.17 | $0.18 | -5.6% | $175.0M | $167.5M | +4.5% |
| 2025-05-06 | $0.26 | $0.19 | +36.8% | $167.5M | $168.2M | -0.4% |
| 2025-02-26 | $0.43 | $0.40 | +7.5% | $179.6M | $172.6M | +4.1% |
| 2024-10-30 | $0.36 | $0.36 | 0.0% | $170.4M | $177.2M | -3.9% |
| 2024-07-31 | $0.34 | $0.29 | +17.2% | $171.7M | $170.7M | +0.6% |
| 2024-05-02 | $0.22 | $0.21 | +4.8% | $166.1M | $170.7M | -2.7% |
| 2024-02-20 | $0.36 | $0.37 | -2.7% | $173.3M | $170.4M | +1.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 701.20M | 687.80M | 673.30M | 684.10M | 744.60M | 714.80M | 697.60M | 652.30M | 611.60M | 566.20M | 1.57B | 1.67B |
| Net Income | (67.90M) | (392.10M) | (61.80M) | 50.50M | 6.30M | (27.20M) | (45.90M) | 57.50M | 79.30M | 39.80M | (426.30M) | 27.10M |
| EPS | -1.58 | -8.53 | -1.33 | 1.08 | 0.13 | -0.57 | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 | 0.58 |
| Total Assets | 1.07B | 1.15B | 1.69B | 1.79B | 1.60B | 1.67B | 1.80B | 1.83B | 2.20B | 2.07B | 2.00B | 2.53B |
| Total Debt | 129.10M | 170.20M | 209.10M | 277.00M | 187.50M | 248.80M | 325.40M | 247.70M | 580.90M | 579.00M | 578.10M | 636.20M |
| Cash & Equivalents | 89.80M | 107.70M | 87.70M | 127.70M | 118.50M | 111.50M | 205.30M | 384.50M | 219.70M | 113.70M | 129.50M | 149.00M |
| Operating Cash Flow | 74.70M | 100.70M | 32.40M | 90.90M | 87.30M | (2.50M) | (74.50M) | (145.60M) | 144.20M | 188.80M | 97.60M | 147.90M |
| Free Cash Flow | 43.10M | 82.90M | 14.60M | 71.60M | 66.30M | (22.70M) | (125.10M) | (194.70M) | 101.00M | 159.70M | 27.20M | 69.40M |
| FCF per Share | N/A | 1.80 | 0.31 | 1.53 | 1.38 | -0.47 | -2.63 | -4.12 | 2.17 | 3.43 | 0.58 | 1.49 |
| Book Value | 778.20M | 828.50M | 1.24B | 1.29B | 1.27B | 1.26B | 1.27B | 1.30B | 1.22B | 1.10B | 1.06B | 1.49B |
| Cash & ST Investments | 89.80M | 107.70M | 87.70M | 127.70M | 118.50M | 111.50M | 205.30M | 384.50M | 219.70M | 113.70M | 129.50M | 149.00M |
| ROC Equity | -0.09 | -0.47 | -0.05 | 0.04 | 0.00 | -0.02 | -0.04 | 0.04 | 0.07 | 0.04 | -0.40 | 0.02 |